{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:28:20Z","timestamp":1789140500921,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,15]]},"DOI":"10.7759\/cureus.86104","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:52:38Z","timestamp":1750056758000},"source":"Crossref","is-referenced-by-count":2,"title":["Timing and Protocols for Microbiome Intervention in Surgical Patients: A Literature Review of Current Evidence"],"prefix":"10.7759","author":[{"given":"Nicol\u00e1s Id\u00e1rraga","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota G","family":"Herrera Giron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alejandro","family":"Arragan Lezama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio Jos\u00e9","family":"Frias Redroban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Omar","family":"Ventura Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Adolfo","family":"Sanic Coj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.106784","article-title":"Changes in the gut microbiome of patients with esophageal cancer: a systematic review and meta-analysis based on 16S gene sequencing technology","volume":"193","author":"Deng J","year":"2024","unstructured":"Deng J, Huang Y, Yu K, Luo H, Zhou D, Li D. Changes in the gut microbiome of patients with esophageal cancer: a systematic review and meta-analysis based on 16S gene sequencing technology. Microb Pathog. 2024, 193:106784. 10.1016\/j.micpath.2024.106784","journal-title":"Microb Pathog"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.05.029","article-title":"Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome","volume":"187","author":"Derosa L","year":"2024","unstructured":"Derosa L, Iebba V, Silva CA, et al.. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome. Cell. 2024, 187:3373-3389.e16. 10.1016\/j.cell.2024.05.029","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2024.02.020","article-title":"The microbiome of the appendix differs in patients with and without appendicitis: a prospective cohort study","volume":"175","author":"Fonnes S","year":"2024","unstructured":"Fonnes S, Mollerup S, Paulsen SJ, Holzknecht BJ, Westh H, Rosenberg J. The microbiome of the appendix differs in patients with and without appendicitis: a prospective cohort study. Surgery. 2024, 175:1482-8. 10.1016\/j.surg.2024.02.020","journal-title":"Surgery"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07667-8","article-title":"An enterococcal phage-derived enzyme suppresses graft-versus-host disease","volume":"632","author":"Fujimoto K","year":"2024","unstructured":"Fujimoto K, Hayashi T, Yamamoto M, et al.. An enterococcal phage-derived enzyme suppresses graft-versus-host disease. Nature. 2024, 632:174-81. 10.1038\/s41586-024-07667-8","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0066","article-title":"Randomized placebo-controlled, biomarker-stratified phase Ib microbiome modulation in melanoma: impact of antibiotic preconditioning on microbiome and immunity","volume":"14","author":"Glitza IC","year":"2024","unstructured":"Glitza IC, Seo YD, Spencer CN, et al.. Randomized placebo-controlled, biomarker-stratified phase Ib microbiome modulation in melanoma: impact of antibiotic preconditioning on microbiome and immunity. Cancer Discov. 2024, 14:1161-75. 10.1158\/2159-8290.CD-24-0066","journal-title":"Cancer Discov"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2024.08.004","article-title":"Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease","volume":"32","author":"Hayase E","year":"2024","unstructured":"Hayase E, Hayase T, Mukherjee A, et al.. Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe. 2024, 32:1621-1636.e6. 10.1016\/j.chom.2024.08.004","journal-title":"Cell Host Microbe"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2024.0184","article-title":"Morbidity after mechanical bowel preparation and oral antibiotics prior to rectal resection: the MOBILE2 randomized clinical trial","volume":"159","author":"Koskenvuo L","year":"2024","unstructured":"Koskenvuo L, Lunkka P, Varpe P, et al.. Morbidity after mechanical bowel preparation and oral antibiotics prior to rectal resection: the MOBILE2 randomized clinical trial. JAMA Surg. 2024, 159:606-14. 10.1001\/jamasurg.2024.0184","journal-title":"JAMA Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-024-01034-z","article-title":"The effect of prebiotic fibre on the gut microbiome and surgical outcomes in patients with prosthetic joint infection (PENGUIN) - study protocol for a randomised, double-blind, placebo-controlled trial (ACTRN12623001273673)","volume":"23","author":"Sharma DK","year":"2024","unstructured":"Sharma DK, Ramadass B, Callary SA, et al.. The effect of prebiotic fibre on the gut microbiome and surgical outcomes in patients with prosthetic joint infection (PENGUIN) - study protocol for a randomised, double-blind, placebo-controlled trial (ACTRN12623001273673). Nutr J. 2024, 23:132. 10.1186\/s12937-024-01034-z","journal-title":"Nutr J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01957-8","article-title":"Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses","volume":"42","author":"Wang M","year":"2024","unstructured":"Wang M, Rousseau B, Qiu K, et al.. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses. Nat Biotechnol. 2024, 42:1263-74. 10.1038\/s41587-023-01957-8","journal-title":"Nat Biotechnol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.53854\/liim-3203-3","article-title":"Clostridioides difficile infection: an update","volume":"32","author":"Salvati F","year":"2024","unstructured":"Salvati F, Catania F, Murri R, Fantoni M, Torti C. Clostridioides difficile infection: an update. Infez Med. 2024, 32:280-91. 10.53854\/liim-3203-3","journal-title":"Infez Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13070580","article-title":"The impact of surgical bowel preparation on the microbiome in colon and rectal surgery","volume":"13","author":"Weaver L","year":"2024","unstructured":"Weaver L, Troester A, Jahansouz C. The impact of surgical bowel preparation on the microbiome in colon and rectal surgery. Antibiotics (Basel). 2024, 13:580. 10.3390\/antibiotics13070580","journal-title":"Antibiotics (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213644","article-title":"Fecal microbiome composition correlates with pathologic complete response in patients with operable esophageal cancer treated with combined chemoradiotherapy and immunotherapy","volume":"16","author":"Shaikh FY","year":"2024","unstructured":"Shaikh FY, Lee S, White JR, et al.. Fecal microbiome composition correlates with pathologic complete response in patients with operable esophageal cancer treated with combined chemoradiotherapy and immunotherapy. Cancers (Basel). 2024, 16:3644. 10.3390\/cancers16213644","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00728-24","article-title":"Changes in the pharyngeal and nasal microbiota in pediatric patients with adenotonsillar hypertrophy","volume":"12","author":"Del Chierico F","year":"2024","unstructured":"Del Chierico F, Piazzesi A, Fiscarelli EV, et al.. Changes in the pharyngeal and nasal microbiota in pediatric patients with adenotonsillar hypertrophy. Microbiol Spectr. 2024, 12:e0072824. 10.1128\/spectrum.00728-24","journal-title":"Microbiol Spectr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/nau.25377","article-title":"How do we make progress in phenotyping patients with LUT such as OAB and underactive detrusor, including using urine markers and microbiome data, in order to personalize therapy? ICI-RS 2023: Part 1","volume":"43","author":"Finazzi Agr\u00f2 E","year":"2024","unstructured":"Finazzi Agr\u00f2 E, Rosato E, Wagg A, et al.. How do we make progress in phenotyping patients with LUT such as OAB and underactive detrusor, including using urine markers and microbiome data, in order to personalize therapy? ICI-RS 2023: Part 1. Neurourol Urodyn. 2024, 43:1261-71. 10.1002\/nau.25377","journal-title":"Neurourol Urodyn"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14846","article-title":"Associations between gut microbiota characteristics and non-motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients","volume":"36","author":"Gorecka-Mazur A","year":"2024","unstructured":"Gorecka-Mazur A, Krygowska-Wajs A, Furgala A, et al.. Associations between gut microbiota characteristics and non-motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients. Neurogastroenterol Motil. 2024, 36:e14846. 10.1111\/nmo.14846","journal-title":"Neurogastroenterol Motil"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03688-5","article-title":"Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients","volume":"24","author":"Liang X","year":"2024","unstructured":"Liang X, Zhu Y, Bu Y, et al.. Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients. BMC Microbiol. 2024, 24:541. 10.1186\/s12866-024-03688-5","journal-title":"BMC Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15040144","article-title":"Comparative changes in fecal microbiome after endoscopic resection and surgical resection in gastric cancer patients","volume":"15","author":"Seo H","year":"2025","unstructured":"Seo H, Park JY, You HS, Kim BJ, Kim JG. Comparative changes in fecal microbiome after endoscopic resection and surgical resection in gastric cancer patients. J Pers Med. 2025, 15:144. 10.3390\/jpm15040144","journal-title":"J Pers Med"},{"key":"ref18","article-title":"Preoperative evaluation and preparation for anesthesia and surgery","volume":"11","author":"Zambouri A","year":"2007","unstructured":"Zambouri A. Preoperative evaluation and preparation for anesthesia and surgery. Hippokratia. 2007, 11:13-21.","journal-title":"Hippokratia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7045","article-title":"The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial","volume":"7","author":"Yang Y","year":"2016","unstructured":"Yang Y, Xia Y, Chen H, et al.. The effect of perioperative probiotics treatment for colorectal cancer: short-term outcomes of a randomized controlled trial. Oncotarget. 2016, 7:8432-40. 10.18632\/oncotarget.7045","journal-title":"Oncotarget"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1590\/0100-69912017006004","article-title":"Perioperative synbiotics administration decreases postoperative infections in patients with colorectal cancer: a randomized, double-blind clinical trial","volume":"44","author":"Flesch AT","year":"2017","unstructured":"Flesch AT, Tonial ST, Contu PC, Damin DC. Perioperative synbiotics administration decreases postoperative infections in patients with colorectal cancer: a randomized, double-blind clinical trial. Rev Col Bras Cir. 2017, 44:567-73. 10.1590\/0100-69912017006004","journal-title":"Rev Col Bras Cir"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2017.04.021","article-title":"Effects of continuous use of probiotics before liver transplantation: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Gr\u0105t M","year":"2017","unstructured":"Gr\u0105t M, Wronka KM, Lewandowski Z, et al.. Effects of continuous use of probiotics before liver transplantation: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2017, 36:1530-9. 10.1016\/j.clnu.2017.04.021","journal-title":"Clin Nutr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-015-3071-z","article-title":"A four-probiotics regimen reduces postoperative complications after colorectal surgery: a randomized, double-blind, placebo-controlled study","volume":"39","author":"Kotzampassi K","year":"2015","unstructured":"Kotzampassi K, Stavrou G, Damoraki G, Georgitsi M, Basdanis G, Tsaousi G, Giamarellos-Bourboulis EJ. A four-probiotics regimen reduces postoperative complications after colorectal surgery: a randomized, double-blind, placebo-controlled study. World J Surg. 2015, 39:2776-83. 10.1007\/s00268-015-3071-z","journal-title":"World J Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-008-0445-9","article-title":"Prebiotics, probiotics, synbiotics in surgery\u2014are they only trendy, truly effective or even dangerous?","volume":"394","author":"Rayes N","year":"2009","unstructured":"Rayes N, Seehofer D, Neuhaus P. Prebiotics, probiotics, synbiotics in surgery\u2014are they only trendy, truly effective or even dangerous?. Langenbecks Arch Surg. 2009, 394:547-55. 10.1007\/s00423-008-0445-9","journal-title":"Langenbecks Arch Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0366-3","article-title":"Normalization of the microbiota in patients after treatment for colonic lesions","volume":"5","author":"Sze MA","year":"2017","unstructured":"Sze MA, Baxter NT, Ruffin MT IV, Rogers MA, Schloss PD. Normalization of the microbiota in patients after treatment for colonic lesions. Microbiome. 2017, 5:150. 10.1186\/s40168-017-0366-3","journal-title":"Microbiome"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2019.73.316-320","article-title":"Usage of probiotics and its clinical significance at surgically treated patients sufferig from colorectal carcinoma","volume":"73","author":"Bajramagic S","year":"2019","unstructured":"Bajramagic S, Hodzic E, Mulabdic A, Holjan S, Smajlovic SV, Rovcanin A. Usage of probiotics and its clinical significance at surgically treated patients sufferig from colorectal carcinoma. Med Arch. 2019, 73:316-20. 10.5455\/medarh.2019.73.316-320","journal-title":"Med Arch"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-015-1178-3","article-title":"Efficacy of perioperative synbiotics treatment for the prevention of surgical site infection after laparoscopic colorectal surgery: a randomized controlled trial","volume":"46","author":"Komatsu S","year":"2016","unstructured":"Komatsu S, Sakamoto E, Norimizu S, Shingu Y, Asahara T, Nomoto K, Nagino M. Efficacy of perioperative synbiotics treatment for the prevention of surgical site infection after laparoscopic colorectal surgery: a randomized controlled trial. Surg Today. 2016, 46:479-90. 10.1007\/s00595-015-1178-3","journal-title":"Surg Today"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2004.08.008","article-title":"A prospective randomised trial of probiotics in critically ill patients","volume":"24","author":"McNaught CE","year":"2005","unstructured":"McNaught CE, Woodcock NP, Anderson AD, MacFie J. A prospective randomised trial of probiotics in critically ill patients. Clin Nutr. 2005, 24:211-9. 10.1016\/j.clnu.2004.08.008","journal-title":"Clin Nutr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2015.1004734","article-title":"Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial","volume":"67","author":"Sommacal HM","year":"2015","unstructured":"Sommacal HM, Bersch VP, Vitola SP, Osvaldt AB. Perioperative synbiotics decrease postoperative complications in periampullary neoplasms: a randomized, double-blind clinical trial. Nutr Cancer. 2015, 67:457-62. 10.1080\/01635581.2015.1004734","journal-title":"Nutr Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2018.06.004","article-title":"Impact of the preoperative use of synbiotics in colorectal cancer patients: a prospective, randomized, double-blind, placebo-controlled study","volume":"58","author":"Polakowski CB","year":"2019","unstructured":"Polakowski CB, Kato M, Preti VB, Schieferdecker ME, Ligocki Campos AC. Impact of the preoperative use of synbiotics in colorectal cancer patients: a prospective, randomized, double-blind, placebo-controlled study. Nutrition. 2019, 58:40-6. 10.1016\/j.nut.2018.06.004","journal-title":"Nutrition"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-015-0260-z","article-title":"Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial","volume":"15","author":"Liu Z","year":"2015","unstructured":"Liu Z, Li C, Huang M, et al.. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial. BMC Gastroenterol. 2015, 15:34. 10.1186\/s12876-015-0260-z","journal-title":"BMC Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-9007(02)00811-0","article-title":"Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery","volume":"18","author":"Rayes N","year":"2002","unstructured":"Rayes N, Hansen S, Seehofer D, M\u00fcller AR, Serke S, Bengmark S, Neuhaus P. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition. 2002, 18:609-15. 10.1016\/S0899-9007(02)00811-0","journal-title":"Nutrition"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01607","article-title":"Comparison of microbiota in patients treated by surgery or chemotherapy by 16S rRNA sequencing reveals potential biomarkers for colorectal cancer therapy","volume":"9","author":"Deng X","year":"2018","unstructured":"Deng X, Li Z, Li G, Li B, Jin X, Lyu G. Comparison of microbiota in patients treated by surgery or chemotherapy by 16S rRNA sequencing reveals potential biomarkers for colorectal cancer therapy. Front Microbiol. 2018, 9:1607. 10.3389\/fmicb.2018.01607","journal-title":"Front Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000259442.78947.19","article-title":"Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial","volume":"246","author":"Rayes N","year":"2007","unstructured":"Rayes N, Seehofer D, Theruvath T, et al.. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg. 2007, 246:36-41. 10.1097\/01.sla.0000259442.78947.19","journal-title":"Ann Surg"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072181","article-title":"Effects of PrObiotics on the Symptoms and Surgical ouTComes after Anterior REsection of Colon Cancer (POSTCARE): a randomized, double-blind, placebo-controlled trial","volume":"9","author":"Park IJ","year":"2020","unstructured":"Park IJ, Lee JH, Kye BH, et al.. Effects of PrObiotics on the Symptoms and Surgical ouTComes after Anterior REsection of Colon Cancer (POSTCARE): a randomized, double-blind, placebo-controlled trial. J Clin Med. 2020, 9:2181. 10.3390\/jcm9072181","journal-title":"J Clin Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa262","article-title":"Gastrointestinal surgery for inflammatory bowel disease persistently lowers microbiome and metabolome diversity","volume":"27","author":"Fang X","year":"2021","unstructured":"Fang X, V\u00e1zquez-Baeza Y, Elijah E, et al.. Gastrointestinal surgery for inflammatory bowel disease persistently lowers microbiome and metabolome diversity. Inflamm Bowel Dis. 2021, 27:603-16. 10.1093\/ibd\/izaa262","journal-title":"Inflamm Bowel Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/378423-timing-and-protocols-for-microbiome-intervention-in-surgical-patients-a-literature-review-of-current-evidence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T06:52:38Z","timestamp":1750056758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/378423-timing-and-protocols-for-microbiome-intervention-in-surgical-patients-a-literature-review-of-current-evidence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,15]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.86104","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,15]]}}}